FiH Safety and Feasibility Study Assessing Intra-articular Administration of aeGF in Patients With Knee Osteoarthritis

NCT06690710 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

BIOLOGICAL: allogeneic engineered Gingival Fibroblasts (aeGF)

Sponsor

Scarcell Therapeutics S.A.S.

Collaborators

[object Object]
[object Object]